RYTM: Rhythm Pharmaceuticals, Inc. 2020-06-24 08:00:10 Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers
Hi guys, Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Long: LMT 1- 19.9$ (20 % of the planned investment amount) LMT 2- 19.21$ (40 % of the planned investment amount) LMT 3- 18,31$ (40 % of the planned investment amount) TP: 31.4$ Comments and likes...
Chart says, that price action is all Bullish for next few and/or several months....insiders are free to trade, so watch for price action, which might go down below the $17 initial stock price of INSIDERS....big picture is buy at this time